Publications

MRI PUBLICATIONS

2020

Gao Y, Zhu X, Moffat BA, Glarin R, Wilman AH, Pike GB, Crozier S, Liu F, Sun H. xQSM: quantitative susceptibility mapping with octave convolutional and noise-regularized neural networks. NMR Biomed. 2020 Dec 27:e4461. doi: 10.1002/nbm.4461. Epub ahead of print. PMID: 33368705.

Gonen OM, Moffat BA, Kwan P, O'Brien TJ, Desmond PM, Lui E. Resting-state functional connectivity and quantitation of glutamate and GABA of the PCC/precuneus by magnetic resonance spectroscopy at 7T in healthy individuals. PLoS One. 2020 Dec 29;15(12):e0244491.

Gonen OM, Moffat BA, Desmond PM, Lui E, Kwan P, O'Brien TJ. Seven-tesla quantitative magnetic resonance spectroscopy of glutamate, γ-aminobutyric acid, and glutathione in the posterior cingulate cortex/precuneus in patients with epilepsy. Epilepsia. 2020 Dec;61(12):2785-2794.

Ordidge R, Cleary J, Glarin R, Blunck Y, Farquharson S, Moffat B. Ultra-high-field MRI using composite RF (STEP) pulses. NMR Biomed. 2020 Nov 17:e4445. doi: 10.1002/nbm.4445. Epub ahead of print.

Marzbanrad F, Yaghmaie N, Jelinek HF. A framework to quantify controlled directed interactions in network physiology applied to cognitive function assessment. Sci Rep. 2020 Oct 28;10(1):18505.

Gonen OM, Moffat BA, Kwan P, O'Brien TJ, Desmond PM, Lui E. Reproducibility of Glutamate, Glutathione, and GABA Measurements in vivo by Single-Voxel STEAM Magnetic Resonance Spectroscopy at 7-Tesla in Healthy Individuals. Front Neurosci. 2020 Sep 15;14:566643.

Kottaram A, Johnston LA, Tian Y, Ganella EP, Laskaris L, Cocchi L, McGorry P, Pantelis C, Kotagiri R, Cropley V, Zalesky A. Predicting individual improvement in schizophrenia symptom severity at 1-year follow-up: Comparison of connectomic, structural, and clinical predictors. Hum Brain Mapp. 2020 Aug;41(12):3342-57.

Yoo PE, Oxley TJ, Hagan MA, John S, Ronayne SM, Rind GS, Brinded AM, Opie NL, Moffat BA, Wong YT. Distinct Neural Correlates Underlie Inhibitory Mechanisms of Motor Inhibition and Motor Imagery Restraint. Front Behav Neurosci. 2020 Jun;14:77.

Kolbe SC, Syeda W, Blunck Y, Glarin R, Law M, Johnston LA, Cleary JO. Microstructural correlates of 23Na relaxation in human brain at 7 Tesla. Neuroimage. 2020 May; 211:116609.

Boonstra FMC, Evans A, Noffs G, Perera T, Jokubaitis V, Stankovich J, Vogel AP, Moffat BA, Butzkueven H, Kolbe SC, van der Walt A OnabotulinumtoxinA treatment for MS-tremor modifies fMRI tremor response in central sensory-motor integration areas. Mult Scler Relat Disord. 2020 May; 40:101984.

Boonstra FM, Noffs G, Perera T, Jokubaitis VG, Vogel AP, Moffat BA, Butzkueven H, Evans A, van der Walt A, Kolbe SC. Functional neuroplasticity in response to cerebello-thalamic injury underpins the clinical presentation of tremor in multiple sclerosis. Mult Scler. 2020 May;26(6):696-705.

Sun H, Cleary JO, Glarin R, Kolbe SC, Ordidge RJ, Moffat BA, Pike GB.Extracting more for less: multi-echo MP2RAGE for simultaneous T1 -weighted imaging, T1 mapping, R 2 * mapping, SWI, and QSM from a single acquisition. Magn Reson Med. 2020 Apr;83(4):1178-91.

Blunck Y, Kolbe SC, Moffat BA, Ordidge RJ, Cleary JO, Johnston LA. Compressed sensing effects on quantitative analysis of undersampled human brain sodium MRI. Magn Reson Med. 2020; Mar; 83(3):1025-33.

2019

Rana S, Shishegar R, Quezada S, Johnston L, Walker DW, Tolcos M. The subplate: a potential driver of cortical folding? Cereb Cortex. 2019 Dec; 29(11): 4697 -4708.

Green EM, Blunck Y, Tahayori B, Farrell PM, Korte JC, Johnston LA. Spin Lock Adiabatic Correction (SLAC) for B1-insensitive pulse design at 7T. J Magn Reson. 2019 Nov; 308: 106565.

Wright DK, Brady RD, Kamnaksh A, Trezise J, Sun M, McDonald SJ, Mychasiuk R, Kolbe SC, Law M, Johnston LA, O'Brien TJ, Agoston DV, Shultz SR. Repeated mild traumatic brain injuries induce persistent changes in plasma protein and magnetic resonance imaging biomarkers in the rat. SciRep 2019 Oct; 9(1) :4626.

Kottaram A, Johnston L, Ganella E, Pantelis C, Kotagiri R, Zalesky A.  Spatio-temporal dynamics of resting-state brain networks improve single-subject prediction of schizophrenia diagnosis. Hum Brain Mapp. 2018 Sep; 39(9): 3663 -81.

Kottaram A, Johnston LA, Cocchi L, Ganella EP, Everall I, Pantelis C, Kotagiri R, Zalesky A. Brain network dynamics in schizophrenia: Reduced dynamism of the default mode network, Hum Brain Mapp. 2019 May; 40(7):2212-28.

Syeda W, Blunck Y, Kolbe S, Cleary JO, Johnston LA.  A continuum of T2* components: Flexible fast fraction mapping in Sodium MRI. Magn Reson Med. 2019 Jun; 81(6), 3854-3864.

Allocca G, Ma S, Martelli D, Cerri M, Del Vecchio F, Bastianini S, Zoccoli G, Amici R, Morairty SR, Aulsebrook AE, Blackburn S, Lesku JA, Rattenborg NC, Vyssotski AL, Wams E, Porcheret K, Wulff K, Foster R, Chan JKM, Nicholas CL, Freestone DR, Johnston LA, Gundlach AL. Validation of ‘Somnivore’, a Machine Learning Algorithm for Automated Scoring and Analysis of Polysomnography Data. Frontiers Neurosci2019 Mar;13:207.

Immonen R, Harris NG, Wright D, Johnston L, Manninen E, Smith G, Paydar A, Branch C, Grohn O.  Imaging biomarkers of epileptogenecity after traumatic brain injury - preclinical frontiers.  NeurobioloDis.2019 Mar 123:75-85.

Blunck Y, Moffat BA, Kolbe SC, Ordidge RJ, Cleary JO, Johnston LA. Zero-Gradient-Excitation Ramped Hybrid Encoding (zGRF-RHE) Sodium MRI. Magn Reson Med. 2019 Feb 81(2):1172-1180.

Immonen R, Smith G, Brady RD, Wright D, Johnston L, Harris NG, Manninen E, Salo R, Branch C, Duncan D, Cabeen R, Ndode-Ekane XE, Gomez CS, Casillas-Espinosa PM, Ali I, Shultz SR, Andrade P, Puhakka N, Staba RJ, O'Brien TJ, Toga AW, Pitkänen A, Gröhn O.  Harmonization of pipeline for preclinical multicenter MRI biomarker discovery in a rat model of post-traumatic epileptogenesis, Epilepsy Res. 2019 Feb; 150:46-57.

Neal A, Moffat BA, Stein JM, Nanga RPR, Desmond P, Shinohara RT, Hariharan H, Glarin R, Drummond K, Morokoff A, Kwan P, Reddy R, O'Brien TJ, Davis KA, Glutamate weighted imaging contrast in gliomas with 7Tesla magnetic resonance imaging. Neuroimage Clin,2019; 22:101694.

2018

Noffs G, Perera T, Kolbe SC, Shanahan CJ, Boonstra FMC, Evans A, Butzkueven H, van der Walt A, Vogel AP. What speech can tell us: A systematic review of dysarthria characteristics in Multiple Sclerosis. Autoimmun Rev. 2018 Dec;17(12):1202-1209.

Yoo PE, Cleary JO, Kolbe SC, Ordidge RJ, O'Brien TJ, Opie NL, John SE, Oxley TJ, Moffat BA.Optimized partial-coverage functional analysis pipeline (OPFAP): a semi-automated pipeline for skull stripping and co-registration of partial-coverage, ultra-high-field functional images. MAGMA.2018 Oct;31(5):621-632.

Boonstra FMC, Perera T, Noffs G, Marotta C, Vogel AP, Evans AH, Butzkueven H, Moffat BA, van der Walt A, Kolbe SC. Novel Functional MRI Task for Studying the Neural Correlates of Upper Limb Tremor. Front Neurol. 2018 Jul 9: 513.

Yoo PE, Hagan MA, John SE, Opie NL, Ordidge RJ, O'Brien TJ, Oxley TJ, Moffat BA, Wong YT.Spatially dynamic recurrent information flow across long-range dorsal motor network encodes selective motor goals. Hum Brain Mapp. 2018 Jun; 39(6): 2635-2650.

Blunck Y, Josan S, Taqdees SW, Moffat BA, Ordidge RJ, Cleary JO, Johnston LA.  3D-multi-echo radial imaging of 23Na (3D-MERINA) for time-efficient multi-parameter tissue compartment mapping. Magn Reson Med. 2018 Apr; 79 (4): 1950-1961.

Kumar SS, Moffat BA, Salinas S, Churilov L, Yan B. An Objective Measurement of Lacunar Infarct Location from the Middle Cerebral Artery Stem. J Stroke Cerebrovasc Dis. 2018 Mar; 27 (3):599-605.

Jenkins LM, Andrewes DG, Nicholas CL, Drummond KJ, Moffat BA, Phal PM, Desmond P. Emotional reactivity following surgery to the prefrontal cortex. J Neuropsychol. 2018 Mar; 12(1):120-141.

Shanahan CJ, Boonstra FMC, Cofré Lizama LE, Strik M, Moffat BA, Khan F, Kilpatrick TJ, van der Walt A, Galea MP, Kolbe SC.  Technologies for Advanced Gait and Balance Assessments in People with Multiple Sclerosis.  Front. Neurol. 2018 Feb; 8:708.

Yoo PE, John SE, Farquharson S, Cleary JO, Wong YT, Ng A, Mulcahy CB, Grayden DB, Ordidge RJ, Opie NL, O'Brien TJ, Oxley TJ, Moffat BA. 7T-fMRI: Faster temporal resolution yields optimal BOLD sensitivity for functional network imaging specifically at high spatial resolution. Neuroimage.2018 Jan; 164:214-229.

Perera T, Lee WL, Yohanandan SAC, Nguyen AL, Cruse B, Boonstra FMC, Noffs G, Vogel AP, Kolbe SC, Butzkueven H, Evans A, van der Walt A.Validation of a precision tremor measurement system for multiple sclerosis, J Neurosci Methods. 2019 Jan; 311: 377-384.

2017

Boonstra F, Florescu G, Evans A, Steward C, Mitchell P, Desmond P, Moffat B, Butzkueven H, Kolbe S, van der Walt A.  Tremor in multiple sclerosis is associated with cerebello-thalamic pathology, A. J Neural Transm (Vienna). 2017Dec: 124(12): 1509-1514.

Field KM, Fitt G, Rosenthal MA, Simes J, Nowak AK, Barnes EH, Sawkins K, Goh C, Moffat BA, Salinas S, Cher L, Wheeler H, Hovey EJ, Phal PM; CABARET/COGNO Investigators. Comparison between site and central radiological assessments for patients with recurrent glioblastoma on a clinical trial. Asia Pac J Clin Oncol. 2018 Oct; 14(5): e359 -e365.

Petzold A, Balcer LJ, Calabresi PA, Costello F, Frohman TC, Frohman EM, Martinez-Lapiscina EH, Green AJ, Kardon R, Outteryck O, Paul F, Schippling S, Vermersch P, Villoslada P, Balk LJ; ERN-EYE IMSVISUAL.  Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol. 2017 Oct;16(10): 797-812.

Gajamange S, Raffelt D, Dhollander T, Lui E, van der Walt A, Kilpatrick T, Fielding J, Connelly A, Kolbe S. Fibre specific white matter changes in multiple sclerosis patients with optic neuritis. Neuro Image Clin. 2017 Sep; 17: 60-8.

Wright DK, Liu S, van der Poel C, McDonald SJ, Brady RD, Taylor L, Yang L, Gardner AJ, Ordidge R, O'Brien TJ, Johnston LA, Shultz SR. Traumatic Brain Injury Results in Cellular, Structural and Functional Changes Resembling Motor Neuron Disease. Cereb Cortex. 2017 Sep; 27(9): 4503-4515.

Ayton S, Fazlollahi A, Bourgeat P, Raniga P, Ng A, Lim YY, Diouf I, Farquharson S, Fripp J, Ames D, Doecke J, Desmond P, Ordidge R, Masters CL, Rowe CC, Maruff P, Villemagne VL; Australian Imaging Biomarkers and Lifestyle (AIBL) Research Group, Salvado O, Bush AI. Cerebral quantitative susceptibility mapping predicts amyloid-β- related cognitive decline. Brain. 2017 Aug 140(8): 2112-2119.

Sharma P, Wright DK, Johnston LA, Powell KL, Wlodek ME, Shultz SR, O'Brien TJ, Gilby KL. Differences in white matter structure between seizure prone (FAST) and seizure resistant (SLOW) rat strains. Neurobiol Dis. 2017 Aug; 104:33-40.

Wright DK, Johnston LA, Kershaw J, Ordidge R, O'Brien TJ, Shultz SR.  Changes in Apparent Fiber Density and Track-Weighted Imaging Metrics in White Matter following Experimental Traumatic Brain Injury. J Neurotrauma. 2017 Jul; 34(13):2109-2118.

Dongworth RK, Campbell-Washburn AE, Cabrera-Fuentes HA, Bulluck H, Roberts T, Price AN, Hernández-Reséndiz S, Ordidge RJ, Thomas DL, Yellon DM, Lythgoe MF, Hausenloy DJ.  Quantifying the area-at-risk of myocardial infarction in-vivo using arterial spin labeling cardiac magnetic resonance. Sci Rep.2017 May; 7(1):2271.

Shelton AL, Cornish KM, Godler D, Bui QM, Kolbe S, Fielding J.  White matter microstructure, cognition, and molecular markers in fragile X premutation females. Neurology. 2017 May; 88(22): 2080-2088.

Tran N, Bye N, Moffat BA, Wright DK, Cuddihy A, Hinton TM, Hawley AM, Reynolds NP, Waddington LJ, Mulet X, Turnley AM, Morganti-Kossmann MC, Muir BW. Dual-modality NIRF-MRI cubosomes and hexosomes: High throughput formulation and in vivo biodistribution.  Dual-modality NIRF-MRI cubosomes and hexosomes: High throughput formulation and in vivo biodistribution. Mater Sci Eng C Mater Biol Appl. 2017 Feb;71: 584-593.

Burrows EL, Eastwood AF, May C, Kolbe SC, Hill T, McLachlan NM, Churilov L, Hannan AJ. Social Isolation Alters Social and Mating Behavior in the R451C Neuroligin Mouse Model of Autism. Neural Plast. 2017; 2017:8361290.

Bennett IE, Field KM, Hovens CM, Moffat BA, Rosenthal MA, Drummond K, Kaye AH, Morokoff AP. Early perfusion MRI predicts survival outcome in patients with recurrent glioblastoma treated with bevacizumab and carboplatin. J Neurooncol. 2017 Jan: 131 (2):321-329.

2016

Shelton AL, Cornish KM, Kolbe S, Clough M, Slater HR, Li X, Kraan CM, Bui QM, Godler DE, Fielding J. Brain structure and intragenic DNA methylation are correlated, and predict executive dysfunction in fragile X premutation females. Transl Psychiatry. 2016 Dec; 6(12): e984.

Shelton AL, Cornish K, Clough M, Gajamange S, Kolbe S, Fielding J.Disassociation between brain activation and executive function in fragile X premutation females. Hum Brain Mapp. 2017 Feb; 38(2): 1056-67.

NUCLEAR MEDICINE PUBLICATIONS

2020

Burnham SC, Laws SM, Budgeon CA, Doré V, Porter T, Bourgeat P, Buckley RF, Murray K, Ellis KA, Turlach BA, Salvado O, Ames D, Martins RN, Rentz D, Masters CL, Rowe CC, Villemagne VL; Alzheimer's Disease Neuroimaging Initiative; AIBL Research Group.  Impact of APOE- -ε4  carriage on the onset and rates of neocortical A β- amyloid deposition. Neurobiol Aging. 2020 Nov; 95:46-55.

Miles LF, Chuen J, Edwards L, Hohmann JD, Williams R, Peyton P, Grayden DB. The design and manufacture of 3D-printed adjuncts for powered air-purifying respirators. Anaesth Rep. 2020 Jul;8(2):e12055.

Nadebaum DP, Krishnadas N, Poon AM, Kalff V, Lichtenstein M, Villemagne VL, Jones G, Rowe CC.  . A head-to-head comparison of cerebral blood flow SPECT and (18) F-FDG PET in the diagnosis of Alzheimer's Disease. Intern Med J. 2020 May 10.

Amadoru S, Doré V, McLean CA, Hinton F, Shepherd CE, Halliday GM, Leyton CE, Yates PA, Hodges JR, Masters CL, Villemagne VL, Rowe CC.Comparison of amyloid PET measured in Centiloid units with neuropathological findings in Alzheimer's disease. Alzheimers Res Ther. 2020 Mar;12(1):22.

Yassi N, Hilal S, Xia Y, Lim YY, Watson R, Kuijf H, Fowler C, Yates P, Maruff P, Martins R, Ames D, Chen C, Rowe CC, Villemagne VL, Salvado O, Desmond PM, Masters CL. Influence of Comorbidity of Cerebrovascular Disease and Amyloid-beta on Alzheimer's Disease. J Alzheimers Dis. 2020;73(3):897-907.

2019

Williams R, Johnston L., Dore V, O'Keefe G, Callahan J, Xu Z, Zheng S, Moffat B, Masters C, and Rowe C. Phantom measurement predicts the impact of image reconstruction on Florbetapir SUVR quantification. J Nucl Med. 2019; 60(Suppl 1): 2001.

2018

Elias A, Cummins T, Tyrrell R, Lamb F, Dore V, Williams R, Rosenfeld JV, Hopwood M, Villemagne VL, Rowe CC.Risk of Alzheimer's Disease in Obstructive Sleep Apnea Syndrome: Amyloid-beta and Tau Imaging.J Alzheimers Dis. 2018; 66(2): 733-741.

Cummins T, Xia Y, Elias A, Lamb F, Pannek K, Doré V, Bourgeat P, Williams R, Salvado O, Fripp J, Ponsford J, Villemagne V, Hopwood M & Rowe C. Tau, Aβ amyloid, brain structure and cognitive function following service-related traumatic brain injury in Australian Vietnam war veterans.Alzheimer's and Dementia 2018 Jul; 14(7):p1417-p1418.

2017

Villemagne, V., V. DorÃ, S. Burnham, P. Bourgeat, T. Cummins, R. Mulligan, R. Williams, O. Salvado, C. Masters and C. Rowe (2017). "Combining categorical and continuous tau burden measures from four different tau tracers: 18F-AV1451, 18F-THK5317, 18F-THK5351, and 18F-MK6420." Journal of Nuclear Medicine 58(supplement 1): 626-626.

Rowe, C. C., V. Dore, P. Bourgeat, R. Williams, D. Ames, O. Salvado, C. L. Masters and V. L. Villemagne (2017). "LONGITUDINAL ASSESSMENT OF Aβ ACCUMULATION WITH FLUTEMETAMOL." Alzheimer's & Dementia: The Journal of the Alzheimer's Association 13(7): P778.

Rowe, C., V. Dore, S. Burnham, P. Bourgeat, T. Cummins, R. Mulligan, R. Williams, O. Salvado, C. Masters and V. Villemagne (2017). EVALUATION OF TAU TRACERS IN NORMAL AGEING AND ALZHEIMER'S DISEASE. INTERNAL MEDICINE JOURNAL, WILEY 111 RIVER ST, HOBOKEN 07030-5774, NJ USA.

Elias, A., T. L. Cummins, M. Hopwood, F. Lamb, V. Dore, R. Williams, V. L. Villemagne and C. C. Rowe (2017). "β-AMYLOID AND TAU IMAGING IN OBSTRUCTIVE SLEEP APNOEA: AUSTRALIAN IMAGING BIOMARKERS AND LIFESTYLE-VETERANS STUDY (AIBL-VETS)." Alzheimer's & Dementia: The Journal of the Alzheimer's Association 13(7): P568.

2016

Rowe C, Doré V, Bourgeat P., Thurfjell L., Macaulay S, Williams R, Salvado O, Ames D, Masters C and Villemagne V. Longitudinal assessment of Aβ accumulation in non-demented individuals: A 18F-flutemetamol study" Journal of Nuclear Medicine (2015). 56(suppl 3): 193-193.

Villemagne VL, Doré V, Yates P, Brown B, Mulligan R, Bourgeat P, Veljanoski R, Rainey-Smith SR, Ong K, Rembach A, Williams R, Burnham SC, Laws SM, Salvado O, Taddei K, Macaulay L, Martins RN, Ames D, Masters CL and Rowe CC En Attendant Centiloid. Advances in Res 2014; 2(12) p723 -729

Zwan, M. D., V. L. Villemagne, V. Dore, R. Buckley, P. Bourgeat, R. Veljanoski, O. Salvado, R. Williams, L. Margison, A. Rembach, S. L. Macaulay, R. Martins, D. Ames, W. M. van der Flier, K. A. Ellis, P. Scheltens, C. L. Masters and C. C. Rowe (2016). "Subjective Memory Complaints in APOEvarepsilon4 Carriers are Associated with High Amyloid-beta Burden." J Alzheimers Dis 49(4): 1115-1122.

Tia Cummins, A. E., Malcolm Hopwood, Jeffrey Rosenfeld, Vincent DorÃ, Fiona Lamb, Robert Williams, Laura Margison, Olivier Salvado, Colin Masters, Victor Villemagne, Christopher Rowe (2016). "Assessing Aβ & tau pathology in Vietnam war veterans with chronic Post-Traumatic Stress Disorder." Journal of Nuclear Medicine 57: 1230-1230.

Rowe, C., G. Jones, V. Dore, S. Pejoska, P. Bourgeat, R. Mulligan, R. Williams, L. Margison, J. Chan, O. Salvado, C. Masters and V. Villemagne (2016). "Implementation and Validation of the Centiloid Transformation for F-18-Nav4694." Internal Medicine Journal 46: 17-17.

Rowe, C., G. Jones, V. Dore, S. Pejoska, P. Bourgeat, R. Mulligan, R. Williams, L. Margison, J. Chan and O. Salvado (2016). IMPLEMENTATION AND VALIDATION OF THE CENTILOID TRANSFORMATION FOR F-18-NAV4694. INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL 111 RIVER ST, HOBOKEN 07030-5774, NJ USA.

Rowe, C., V. Dore, P. Bourgeat, T. Cummings, S. Pejoska, R. Mulligan, R. Williams, O. Salvado, C. Masters and V. Villemagne (2016). THE TAU METER SCALE FOR CONTINUOUS AND CATEGORICAL MEASURES OF TAU DEPOSITS IN THE BRAIN: RESULTS FROM 18F-AV1451 AND 18F-THK5351 TAU IMAGING STUDIES. INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL 111 RIVER ST, HOBOKEN 07030-5774, NJ USA.

Rowe, C., V. Dore, P. Bourgeat, T. Cummings, S. Pejoska, R. Mulligan, R. Williams, O. Salvado, C. Masters and V. Villemagne (2016). "The Tau Meter Scale for Continuous and Categorical Measures of Tau Deposits in the Brain: Results from 18f-Av1451 and 18f-Thk5351 Tau Imaging Studies." Internal Medicine Journal 46(pp. 17-17): 17-17.

Rowe, C., T. Cummins, A. Elias, M. Hopwood, J. Rosenfeld, V. Dore, F. Lamb, R. Williams, O. Salvado, L. Margison, C. Masters and V. Villemagne (2016). "IN VIVO ASSESSMENT OF MARKERS OF A beta & TAU PATHOLOGY IN VIETNAM WAR VETERANS WITH CHRONIC POST-TRAUMATIC STRESS DISORDER." Internal Medicine Journal 46: 16-16.

Rowe, C., V. Dore, P. Bourgeat, T. Cummings, S. Pejoska, R. Mulligan, R. Williams, O. Salvado, C. Masters, and V. Villemagne. (2016). "THE TAU METER SCALE FOR CONTINUOUS AND CATEGORICAL MEASURES OF TAU DEPOSITS IN THE BRAIN: RESULTS FROM 18F-AV1451 AND 18F-THK5351 TAU IMAGING STUDIES." INTERNAL MEDICINE JOURNAL 46(pp. 17-17).

Cummins, T., A. Elias, M. Hopwood, J. Rosenfeld, V. DorÃ, F. Lamb, R. Williams, L. Margison, O. Salvado and C. Masters (2016). "Assessing Aβ & tau pathology in Vietnam war veterans with chronic Post-Traumatic Stress Disorder." Journal of Nuclear Medicine 57(supplement 2): 1230-1230.

Christopher C Rowe, V. D., Pierrick Bourgeat, Belinda M Brown, Lennart Thurfjell, Lance Macaulay, Robert Williams, Olivier Salvado, Ralph N Martins, David Ames, Colin L Masters, Victor L Villemagne (2016). "Aβ accumulation in non-demented individuals: A longitudinal F-18-flutemetamol study." Alzheimer's & Dementia: The Journal of the Alzheimer's Association 11(7).

Zwan, M. D., V. L. Villemagne, V. Dore, R. Buckley, P. Bourgeat, R. Veljanoski, O. Salvado, R. Williams, L. Margison, A. Rembach, S. L. Macaulay, R. Martins, D. Ames, W. M. van der Flier, K. A. Ellis, P. Scheltens, C. L. Masters and C. C. Rowe (2015). "Subjective Memory Complaints in APOEvarepsilon4 Carriers are Associated with High Amyloid-beta Burden." J Alzheimers Dis 49(4): 1115-1122.

Villemagne, V. L., P. Bourgeat, V. Doré, L. Macaulay, R. Williams, D. Ames, R. N. Martins, O. Salvado, K. Chen and E. M. Reiman (2015). "Amyloid imaging in therapeutic trials: The quest for the optimal reference region." Alzheimer's & Dementia 11(7): P21-P22.

Victor L Villemagne, P. B., Vincent Doré, Lance Macaulay, Robert Williams, David Ames, Ralph N Martins, Olivier Salvado, Kewei Chen, Eric M Reiman, Colin L Masters, Christopher C Rowe (2015). "Amyloid imaging in therapeutic trials: The quest for the optimal reference region." Alzheimer's & Dementia: The Journal of the Alzheimer's Association 11(7).

Rowe, C. C., V. Doré, P. Bourgeat, B. M. Brown, L. Thurfjell, L. Macaulay, R. Williams, O. Salvado, R. N. Martins and D. Ames (2015). "Aβ accumulation in non-demented individuals: A longitudinal F-18-flutemetamol study." Alzheimer's & Dementia 11(7): P125.

Rowe, C., V. Doré, P. Bourgeat, L. Thurfjell, S. Macaulay, R. Williams, O. Salvado, D. Ames, C. Masters and V. Villemagne (2015). "Longitudinal assessment of Aβ accumulation in non-demented individuals: A 18F-flutemetamol study." Journal of Nuclear Medicine 56(supplement 3): 193-193.

Marissa D Zwan, V. L. V., Vincent Doré, Rachel Buckley, Pierrick Bourgeat, Robyn Veljanoski, Olivier Salvado, Rob Williams, Laura Margison, Alan Rembach, S Lance Macaulay, Ralph Martins, David Ames, Wiesje M van der Flier, Kathryn A Ellis, Philip Scheltens, Colin L Masters, Christopher C Rowe (2015). "Subjective Memory Complaints in APOEɛ4 Carriers are Associated with High Amyloid-β Burden." Journal of Alzheimer's Disease 49.

Rowe, C. C., V. Dore, P. Bourgeat, R. Buckley, R. Veljanovski, O. Salvado, K. Ong, R. Williams, A. Rembach and L. Macaulay (2014). "HIGHER AB BURDEN IN HEALTHY APOE-E4 CARRIERS IS ASSOCIATED WITH SUBJECTIVE MEMORY COMPLAINTS: RESULTS FROM THE FLUTEMETAMOL AND PIB AIPL COHORTS." Alzheimer's & Dementia: The Journal of the Alzheimer's Association 10(4): P186-P187.

Rowe, C., V. Dore, P. Bourgeat, R. Buckley, R. Veljanovski, R. Williams, K. Ong, D. Ames, C. Masters and V. Villemagne (2014). "Higher A {beta} burden in subjective memory complainers: A flutemetamol sub-study in AIBL." Society of Nuclear Medicine Annual Meeting Abstracts 55(Supplement 1): 191.

Jones, G., G. O'Keefe, R. Veljanovski, R. Williams, C. L. Masters, C. C. Rowe and V. L. Villemagne (2014). "ASSESSING THE ACCURACY OF A CT-BASED APPROACH TO THE PARTIAL VOLUME CORRECTION OF FLUTEMETAMOL-PET IMAGES." Alzheimer's & Dementia: The Journal of the Alzheimer's Association 10(4): P110.

Jones, G., G. O'Keefe, R. Veljanovski, R. Williams, C. Masters, C. Rowe and V. Villemagne (2014). "Assessing the accuracy of a ct-based approach to the partial volume correction of flutemetamol-pet images." Alzheimer's & Dementia: The Journal of the Alzheimer's Association 10(4): P110.

R. Williams, Bourgeat. P, C. C. Rowe, O. Salvado, V. L. Villemagne, V. Dore and N. Killeen (2014). "DOES ENHANCED RECONSTRUCTION METHODOLOGY CHANGE THE QUANTIFICATION OF AMYLOID PET WITH FLUMETAMOL?" Alzheimer's & Dementia: The Journal of the Alzheimer's Association 10(4): P401-P402.